ABSIAbsci Corp
Services-Commercial Physical & Biological Research
- Revenue
- $3M
- 38% YoY
- Operating margin
- -4297.0%
- 79% YoY
- EBITDA
- −$109M
- 14% YoY
- Market cap
- $1.3B
- Employees
- 140
- $20K revenue each
- Net debt / EBITDA
- —
- −$104M net debt
- AI in 10-K
- 13.7
- mentions per 10K words
Takeover score 4 of 13
Fixable underperformance 2 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo—Cash flow under 80% of net income
- Dilutive SBCYes654% of revenueOver 10% of revenue
- Payouts exceed cash flowNo0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo0% of assetsOver 40% of assets
- Shareholder dissentYes70% lowest supportAny vote under 80% support
Buyer economics 2 of 4
- Low revenue per employeeYes$20K · 4th pctBottom quartile of its SIC industry
- Quiet on AINo13.7 per 10K words · 96th pctBottom quartile of AI mentions in 10-Ks
- Net cashNo—More cash than debt, positive EBITDA
- Buyout-sizedYes$1.3B market capMarket cap $500M–$5B
Catalysts 0 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingNo$801K netNet sales over $10M in 12 months
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $4M | $5M | $6M | $5M | $3M | 38% |
| Operating income | −$75M | −$107M | −$116M | −$109M | −$120M | 10% |
| Net income | −$101M | −$105M | −$111M | −$103M | −$115M | 12% |
| Operating cash flow | −$61M | −$81M | −$65M | −$72M | −$93M | 28% |
| Capex | $38M | $16M | $860K | $404K | $1M | 174% |
| Stock-based comp | $11M | $13M | $11M | $19M | $18M | 5.8% |
Deal filings
None.
13D filers
| Filed | Filer | Form | Stake | Intent |
|---|---|---|---|---|
| Apr 14, 2026 | Redmile Group, LLC | SCHEDULE 13D/A | 4.9% | Passive |
| Mar 26, 2026 | Redmile Group, LLC | SCHEDULE 13D/A | 5.4% | Passive |
| Apr 29, 2025 | Redmile Group, LLC | SCHEDULE 13D/A | 6.5% | Passive |
| Mar 5, 2024 | Redmile Group, LLC | SC 13D/A | 7.4% | Passive |
| May 8, 2023 | Casdin Capital, LLC | SC 13D/A | 4.8% | Passive |
| Mar 20, 2023 | Casdin Capital, LLC | SC 13D/A | 6.0% | Passive |
| Feb 13, 2023 | Casdin Capital, LLC | SC 13D/A | 7.0% | Passive |
| Jul 21, 2022 | Casdin Capital, LLC | SC 13D/A | 8.3% | Passive |
| Aug 2, 2021 | Redmile Group, LLC | SC 13D | 8.7% | Passive |
| Jul 29, 2021 | Casdin Capital, LLC | SC 13D | 8.5% | Passive |
Insider trading
- Open-market buys, 12 mo
- $933K · 5
- Open-market sells, 12 mo
- $132K · 2
- Net
- $801K
Pay vs performance
No pay-versus-performance disclosure yet.